N-substituted piperidines and their use as pharmaceuticals
US8071624B2 · kind B2 · utility
24Cited by
33References
43Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 23, 2005 |
| Grant date | Dec 6, 2011 |
| Priority date | — |
| Expiry date | Aug 27, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to inhibitors of 11-β hydroxyl steroid dehydrogenase type 1, antagonists of the mineralocorticoid receptor (MR), and pharmaceutical compositions thereof. The compounds of the invention can be useful in the treatment of various diseases associated with expression or activity of 11-β hydroxyl steroid dehydrogenase type 1 and/or diseases associated with aldosterone excess.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.